Johnson & Johnson (NYSE:JNJ) is one of the 10 Best Dip Stocks to Buy According to Billionaires. On June 26, J.P. Morgan analyst Chris Schott maintained their Hold Rating on Johnson & Johnson (NYSE:JNJ ...

When Naomi Osaka opened up about her anxiety and depression at the 2021 French Open, it sparked a conversation in sports — ...

Johnson & Johnson (NYSE:JNJ) ranks among the best set-it-and-forget-it stocks to buy. Asad Haider, a Goldman Sachs analyst, ...

Mental health has not always been talked about within communities of color, but that is starting to shift because of people ...

Many of the traditions we know today began in postwar America — including the very color of many modern wedding dresses.

Bryan Kohberger has agreed to plead guilty to murdering four University of Idaho students as part of a deal with prosecutors ...

Sonya Johnson, 41, started taking drugs at age 11, when a man who was sexually abusing her gave them to her behind her ...

Mark Duplass, best known as Chip Black on the Apple TV+ series, recently opened up about his long and personal journey with mental health.

Johnson & Johnson Discontinues Pivotal Depression Drug Trial Due to Lack of Efficacy J&J said aticaprant showed insufficient efficacy in a Phase 3 test in major depressive disorder.

Johnson & Johnson (NYSE:JNJ) has decided to discontinue a Phase 3 program for its depression therapy aticaprant due to insufficient efficacy, the pharma giant announced. Known as VENTURA, the ...

Johnson & Johnson’s other depression drug Spravato (esketamine), in January, received FDA approval as the only monotherapy for adults living with major depressive disorder who have had an ...